|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2100053397 |
|
最近更新日期: Date of Last Refreshed on: |
2021-11-20 18:58:00 |
|
注册时间: Date of Registration: |
2021-11-20 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
江苏省子痫前期风险预测研究项目 |
|
Public title: |
Research project on risk prediction of preeclampsia in Jiangsu Province |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
江苏省子痫前期风险预测研究项目 |
|
Scientific title: |
Research project on risk prediction of preeclampsia in Jiangsu Province |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
朱媛媛 |
研究负责人: |
孙丽洲 |
|
Applicant: |
Zhu Yuanyuan |
Study leader: |
Sun Lizhou |
|
申请注册联系人电话: Applicant telephone: |
15806292250 |
研究负责人电话: Study leader's telephone: |
13605171213 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
2431073861@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
lizhou_sun@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
南京医科大学第一附属医院 |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
|
|
申请注册联系人通讯地址: |
江苏省南京市鼓楼区江东街道江东北路368号江苏省妇幼保健院 |
研究负责人通讯地址: |
江苏省南京市鼓楼区江东街道江东北路368号江苏省妇幼保健院 |
|
Applicant address: |
Jiangsu Maternal and Child Health Hospital, 368 Northeast Jiang Road, Jiangdong Street, Gulou District, Nanjing City, Jiangsu Province |
Study leader's address: |
Jiangsu Maternal and Child Health Hospital, 368 Northeast Jiang Road, Jiangdong Street, Gulou District, Nanjing City, Jiangsu Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
南京医科大学第一附属医院 |
||
|
Applicant's institution: |
The first affiliated Hospital of Nanjing Medical University |
||
|
研究负责人所在单位: |
南京医科大学第一附属医院 |
||
|
Affiliation of the Leader: |
The first affiliated Hospital of Nanjing Medical University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2021-SR-055 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
南京医科大学第一附属医院 |
||
|
Name of the ethic committee: |
The first affiliated Hospital of Nanjing Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2021-02-08 00:00:00 |
||
|
伦理委员会联系人: |
张馥敏 |
||
|
Contact Name of the ethic committee: |
Zhang Fumin |
||
|
伦理委员会联系地址: |
南京市广州路300号江苏省人民医院药学楼3楼 |
||
|
Contact Address of the ethic committee: |
3 / F, Pharmaceutical Building, Jiangsu Provincial people's Hospital, 300 Guangzhou Road, Nanjing |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
025-68306360 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
2431073861@qq.com |
|
研究实施负责(组长)单位: |
南京医科大学第一附属医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The first affiliated Hospital of Nanjing Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
江苏省南京市广州路300号江苏省人民医院 |
||||||||||||||||||||||
|
Primary sponsor's address: |
Jiangsu Provincial people's Hospital, No. 300 Guangzhou Road, Nanjing, Jiangsu Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
江苏省妇幼健康研究会 |
||||||||||||||||||||||
|
Source(s) of funding: |
Jiangsu Maternal and Child Health Research Association |
||||||||||||||||||||||
|
Target disease: |
Preeclampsia |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||
|
研究目的: |
本研究为江苏省妇幼健康研究会立项委托研究课题,拟多中心通过对江苏省妊娠期妇女的子痫前期风险筛查,评价孕早期子痫前期风险预测模型(母体因素联合MAP、PLGF和UtPI)对江苏省妊娠期妇女子痫前期的发生风险预测的适用性,并探索联合孕中晚期PLGF检测对子痫前期高风险及疑似子痫前期孕妇发生子痫前期及早产的价值。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study is a project commissioned by Jiangsu Maternal and Child Health Research Association to evaluate the applicability of early pregnancy preeclampsia risk prediction model (maternal factors combined with MAP, PLGF and UtPI) to predict the risk of preeclampsia among pregnant women in Jiangsu Province by screening the risk of preeclampsia in Jiangsu Province. And to explore the value of combined detection of PLGF in the second and third trimester of pregnancy for preeclampsia and premature delivery in pregnant women with high risk of preeclampsia and suspected preeclampsia. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1)年龄≥18周岁; |
||||||||||||||||||||||
|
Inclusion criteria |
1) ≥ 18 years old; 2) 11-13 weeks of pregnancy; 3) singleton pregnancy, fetal survival; 4) voluntary participation and signing of informed consent. |
||||||||||||||||||||||
|
排除标准: |
1)双胎或多胎妊娠;2)胎儿严重畸形/异常;3)严重精神障碍,无法表达意愿者;4)存在明显其他异常体征、实验室检查和其他临床疾病,经研究者判断,不适合参加研究者;5)研究者判断,无法观察、随访获得分娩信息者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1) twins or multiple pregnancies; 2) severe fetal malformations / abnormalities; 3) severe mental disorders, unable to express volunteers; 4) obvious other abnormal physical signs, laboratory examinations and other clinical diseases, judged by the researchers, it is not suitable to participate in the researcher; 5) the researcher judged that the delivery information could not be obtained by observation and follow-up. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2021-11-30 00:00:00至 To 2022-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2021-11-30 00:00:00 至 To 2022-06-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
本研究为多中心临床研究,各中心以简单随机法入组门诊就诊的妊娠早期孕妇。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
This study is a multicenter clinical study of early pregnant women who were randomly enrolled in the outpatient clinic in each center. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
NO |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表及Aucheer Lucina智慧妇幼管理系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF and Aucheer Lucina |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |